NDC 80425-0286-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0286
- Requested NDC
- 80425-0286-01
- Package NDCs from labels
- 80425-0286-1, 80425-0286-2, 80425-0286-3, 80425-0286-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0286-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0286-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0286-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0286 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f781d400-7304-5d3e-e053-6294a90ac572.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0286-1 | EA - Each | 80425-0286 | 204f7796-3c4f-4719-93c8-7a1084b8962e | 1 | 2023-06-06 |
| 80425-0286-2 | EA - Each | 80425-0286 | 66317593-8b16-4f73-94d5-db65019f5507 | 1 | 2023-06-06 |
| 80425-0286-3 | EA - Each | 80425-0286 | f3e4f0c9-3825-4fea-8d0f-a4872e480868 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| gabapentin | GABAPENTIN | Zydus Pharmaceuticals USA Inc. | 3cfd04ab-e421-441f-a10e-e4dd1412974d | 2025-09-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | b1a9808d-31a5-4b63-afd0-d96d5a0ad7a1 | 2025-09-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 74474aa4-4859-42d2-92d8-f23f18b34e04 | 2025-08-21 | Warnings, Adverse reactions | ANDA075477 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | 2cb1ad6d-d389-4564-e063-6394a90a3644 | 2025-08-19 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 137b2b9a-9d42-48d0-913f-5dc146fb689a | 2025-08-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 9ead7825-d11b-4e00-8533-328d097b8f83 | 2025-08-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | a88edb00-2189-4c8d-9dd7-9fe1571775cc | 2025-08-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 707ed63a-67ca-4a62-9cbe-cdeb5c4ab506 | 2025-08-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 618c948d-deee-44e2-98f0-e5232171dd50 | 2025-08-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25 | 2025-07-28 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2278ce1b-1c19-4ad2-89c6-4530f7b78ea7 | 2025-07-14 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | 9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a | 2025-07-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 3f2e3ac5-5233-fd57-e063-6294a90a849e | 2025-07-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 7c3b232a-3e9f-4249-9e5a-295482ee288a | 2025-06-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | f7c1fd34-d615-43a2-8989-898fe11f90df | 2025-06-25 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | d25daaac-a8ab-4f12-acc2-4ec8fc97a2d4 | 2025-06-24 | Warnings, Adverse reactions | 310430 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | QUALLENT PHARMACEUTICALS HEALTH LLC | 472bb279-bb4e-4246-b2a3-172483ba356b | 2025-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | bec31452-b52b-4698-ba4c-0b614780ee84 | 2025-06-14 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151 | 2025-06-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 561f53d5-5301-42b3-b372-f3d49d642a2e | 2025-06-11 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.